cholangiocarcinoma of the extrahepatic bile duct

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrence After Whipple's (RAW) Study

Active, not recruiting
  • Pancreatic Cancer
  • +13 more
  • Pancreaticoduodenectomy
  • Clayton, Victoria, Australia
  • +28 more
Jan 13, 2023

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +39 more
  • Chicago, Illinois
  • +1 more
May 7, 2020

EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice

Completed
  • Pancreatic Cancer
  • +3 more
  • Endoscopic ultrasound
  • Bucharest, Romania
    Gastroenterology Department, Clinical Hospital Colentina
Apr 26, 2020

Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (mutation and signal pathway activation

Unknown status
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Gallbladder Cancer
  • mutation and signal pathway activation status analysis Drug: FORFIRINOX
  • Shanghai, Shanghai, China
    Xinhua Hospital
Dec 10, 2018

Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (conventional chemo(FORFIRINOX) combined

Unknown status
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Gallbladder Cancer
  • conventional chemotherapy(FORFIRINOX) combined with target agents
  • conventional chemotherapy(FORFIRINOX)
  • Shanghai, Shanghai, China
    Xinhua Hospital
Dec 6, 2018

Hepatocellular Carcinoma, Cholangiocellular Carcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct Trial in San Francisco,

Terminated
  • Hepatocellular Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Jun 27, 2018

Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (biological test, GEMOX, Cetuximab)

Unknown status
  • Cholangiocarcinoma of the Extrahepatic Bile Duct
  • Gallbladder Cancer
  • biological test
  • +8 more
  • Shanghai, Shanghai, China
    Xinhua Hospital
May 4, 2018

Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct

Terminated
  • Adult Primary Cholangiocellular Carcinoma
  • +10 more
  • cediranib maleate
  • +3 more
  • Cleveland, Ohio
  • +6 more
Feb 10, 2017

B-Receptor Signaling in Cardiomyopathy

Completed
  • Carcinomas
  • +37 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 16, 2015

    Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct, Ampullary Carcinoma Trial in Beijing

    Unknown status
    • Intrahepatic Cholangiocarcinoma
    • +3 more
    • radioactive stent
    • plastic stent
    • Beijing, Beijing, China
      307 hospital of PLA
    Sep 10, 2014

    Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in

    Terminated
    • Adult Primary Cholangiocellular Carcinoma
    • +13 more
    • Chicago, Illinois
      University of Chicago
    May 13, 2014

    Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in

    Completed
    • Adult Primary Cholangiocellular Carcinoma
    • +10 more
    • erlotinib hydrochloride
    • laboratory biomarker analysis
    • Rochester, Minnesota
      Mayo Clinic
    Jun 3, 2013

    Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Unresectable Extrahepatic Bile Duct

    Withdrawn
    • Cholangiocarcinoma of the Extrahepatic Bile Duct
    • +5 more
    • porfimer sodium
    • +4 more
    • Los Angeles, California
    • +1 more
    Apr 2, 2013

    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the

    Completed
    • Adenocarcinoma of the Extrahepatic Bile Duct
    • +9 more
    • sorafenib tosylate
    • laboratory biomarker analysis
    • San Antonio, Texas
      Southwest Oncology Group
    Jan 11, 2013